Sort   by:  
 Page size 
UnknownCetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205).
Not available
S-EPMC5455423 | biostudies-literature
ProteomicsMechanism of enhancing chemotherapy efficacy in pancreatic ductal adenocarcinoma with paricalcitol and hydroxychloroquine
Proteomic and single-cell RNAseq analyses reveal that GPH treatment upregulates autophagy and ER stress-related transcripts.
ORGANISM(S): Mus Musculus 
2024-11-20 | PXD058067 |
Sort   by:  
 Page size